Tarek A Hammad

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. doi request reprint Reporting of meta-analyses of randomized controlled trials with a focus on drug safety: an empirical assessment
    Tarek A Hammad
    Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 30993, USA
    Clin Trials 10:389-97. 2013
  2. doi request reprint Onset of acute myocardial infarction after use of non-steroidal anti-inflammatory drugs
    Tarek A Hammad
    Office of Surveillance and Epidemiology, Food and Drug Administration, Silver Spring, MD 20993 0002, USA
    Pharmacoepidemiol Drug Saf 17:315-21. 2008
  3. doi request reprint Secondary use of randomized controlled trials to evaluate drug safety: a review of methodological considerations
    Tarek A Hammad
    Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U S Food and Drug Administration, Silver Spring, MD 20993, USA
    Clin Trials 8:559-70. 2011
  4. doi request reprint Determining the predictive value of Read/OXMIS codes to identify incident acute myocardial infarction in the General Practice Research Database
    Tarek A Hammad
    Office of Surveillance and Epidemiology, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993 0002, USA
    Pharmacoepidemiol Drug Saf 17:1197-201. 2008
  5. pmc Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration
    Marc Stone
    Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993 0002, USA
    BMJ 339:b2880. 2009
  6. doi request reprint Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008
    Ann W McMahon
    Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA
    Pharmacoepidemiol Drug Saf 19:921-33. 2010
  7. doi request reprint Identifying patterns of adverse event reporting for four members of the angiotensin II receptor blockers class of drugs: revisiting the Weber effect
    Mara A McAdams
    Office of Surveillance and Epidemiology, Food and Drug Administration, Silver Spring, MD 20993 0002, USA
    Pharmacoepidemiol Drug Saf 17:882-9. 2008
  8. doi request reprint Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions
    Carol A Pamer
    FDA Office of Surveillance and Epidemiology, Silver Spring, MD 20993, United States
    Pharmacoepidemiol Drug Saf 19:158-74. 2010
  9. doi request reprint Atomoxetine use during a period of FDA actions
    Dongyi Tony Du
    Office of Commissioner, US Food and Drug Administration FDA, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA
    Med Care 50:987-92. 2012
  10. ncbi request reprint Suicide rates in short-term randomized controlled trials of newer antidepressants
    Tarek A Hammad
    Division of Neuropharmocological Drug Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993 0002, USA
    J Clin Psychopharmacol 26:203-7. 2006

Collaborators

Detail Information

Publications14

  1. doi request reprint Reporting of meta-analyses of randomized controlled trials with a focus on drug safety: an empirical assessment
    Tarek A Hammad
    Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 30993, USA
    Clin Trials 10:389-97. 2013
    ..However, PRISMA may not cover all critical elements useful in the evaluation of meta-analyses with a focus on drug safety particularly in the regulatory-public health setting...
  2. doi request reprint Onset of acute myocardial infarction after use of non-steroidal anti-inflammatory drugs
    Tarek A Hammad
    Office of Surveillance and Epidemiology, Food and Drug Administration, Silver Spring, MD 20993 0002, USA
    Pharmacoepidemiol Drug Saf 17:315-21. 2008
    ....
  3. doi request reprint Secondary use of randomized controlled trials to evaluate drug safety: a review of methodological considerations
    Tarek A Hammad
    Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U S Food and Drug Administration, Silver Spring, MD 20993, USA
    Clin Trials 8:559-70. 2011
    ..Their potential limitations might be exacerbated in the study of rare outcomes, often encountered in drug safety assessment, when even minor deviations from the intended randomization could impact the stability of the risk estimates...
  4. doi request reprint Determining the predictive value of Read/OXMIS codes to identify incident acute myocardial infarction in the General Practice Research Database
    Tarek A Hammad
    Office of Surveillance and Epidemiology, Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993 0002, USA
    Pharmacoepidemiol Drug Saf 17:1197-201. 2008
    ....
  5. pmc Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration
    Marc Stone
    Center for Drug Evaluation and Research, US Food and Drug Administration, 10903 New Hampshire Avenue, Silver Spring, MD 20993 0002, USA
    BMJ 339:b2880. 2009
    ..To examine the risk of suicidal behaviour within clinical trials of antidepressants in adults...
  6. doi request reprint Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008
    Ann W McMahon
    Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA
    Pharmacoepidemiol Drug Saf 19:921-33. 2010
    ..The investigation identified Baxter Healthcare-brand heparin product due to its strongest association with the events. Later, oversulfated chondroitin sulfate (OSCS), a heparin-like contaminant, was discovered...
  7. doi request reprint Identifying patterns of adverse event reporting for four members of the angiotensin II receptor blockers class of drugs: revisiting the Weber effect
    Mara A McAdams
    Office of Surveillance and Epidemiology, Food and Drug Administration, Silver Spring, MD 20993 0002, USA
    Pharmacoepidemiol Drug Saf 17:882-9. 2008
    ....
  8. doi request reprint Changes in US antidepressant and antipsychotic prescription patterns during a period of FDA actions
    Carol A Pamer
    FDA Office of Surveillance and Epidemiology, Silver Spring, MD 20993, United States
    Pharmacoepidemiol Drug Saf 19:158-74. 2010
    ....
  9. doi request reprint Atomoxetine use during a period of FDA actions
    Dongyi Tony Du
    Office of Commissioner, US Food and Drug Administration FDA, 10903 New Hampshire Ave, Silver Spring, MD 20993, USA
    Med Care 50:987-92. 2012
    ..At FDA's request, the manufacturer subsequently added a boxed warning to the drug's labeling on November 8, 2005...
  10. ncbi request reprint Suicide rates in short-term randomized controlled trials of newer antidepressants
    Tarek A Hammad
    Division of Neuropharmocological Drug Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993 0002, USA
    J Clin Psychopharmacol 26:203-7. 2006
    ....
  11. doi request reprint Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children
    Andrew D Mosholder
    Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 20993 0002, USA
    Pediatrics 123:611-6. 2009
    ....
  12. doi request reprint ABO phenotype and other risk factors associated with chorioamnionitis
    Hany Aly
    Department of Pediatrics, George Washington University, Washington, DC Department of Obstetrics, George Washington University, Washington, DC, USA
    J Pediatr 153:16-8. 2008
    ..To examine risk factors associated with chorioamnionitis...
  13. ncbi request reprint Oral Ibuprofen and ductus arteriosus in premature infants: a randomized pilot study
    Hany Aly
    Newborn Services Department, The George Washington University Hospital, Washington, District of Columbia 20037, USA
    Am J Perinatol 24:267-70. 2007
    ..22 versus -0.06 +/- 0.19 mg/dL; P = 0.13). Two infants in group I had severe pulmonary hemorrhage, whereas there were none in the group O. Oral ibuprofen could be an easy-to-administer and efficacious alternative in the treatment of PDA...
  14. ncbi request reprint Predictors of nosocomial bloodstream infections among critically ill adult trauma patients
    Maher M El-Masri
    University of Windsor, Faculty of Nursing, 401 Sunset, CHN Room G110, Windsor, Ontario, Canada N9B 3P4
    Infect Control Hosp Epidemiol 25:656-63. 2004
    ..To identify the independent predictors of nosocomial bloodstream infections (BSIs) among critically ill adult trauma patients...